2004
DOI: 10.1158/0008-5472.can-03-2031
|View full text |Cite
|
Sign up to set email alerts
|

Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice

Abstract: The PATCHED (PTC) gene is recognized as a tumor suppressor in basal cell carcinoma. Mapping of a minimal region of deletion at 9q22.3 and observation of a decreased PTC expression in superficial papillary bladder tumors led us to hypothesize that it could also be involved in this cancer. To further investigate this hypothesis, we submitted Ptc ϩ/Ϫ heterozygous mutant mice and their wild-type littermates to chemical carcinogenesis by adding N-butyl-N-(4-hydroxybutyl) nitrosamine to their drinking water. Preneop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
13
0
3

Year Published

2006
2006
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 17 publications
1
13
0
3
Order By: Relevance
“…This hyperactivation might then accelerate the growth of a tumor initiated by a BBN-induced p53 mutation and influence CIS and nonpapillary TCC to become papillary. It should be noted that, compared with our observations, previous studies using the BBN-induced tumor model reported higher frequencies of bladder cancers at earlier times in WT mice (28,39). These differences may be due to the relatively low dose of BBN given in our study, the more advanced age of our mice, or the variations in genetic background.…”
Section: Discussionsupporting
confidence: 54%
See 2 more Smart Citations
“…This hyperactivation might then accelerate the growth of a tumor initiated by a BBN-induced p53 mutation and influence CIS and nonpapillary TCC to become papillary. It should be noted that, compared with our observations, previous studies using the BBN-induced tumor model reported higher frequencies of bladder cancers at earlier times in WT mice (28,39). These differences may be due to the relatively low dose of BBN given in our study, the more advanced age of our mice, or the variations in genetic background.…”
Section: Discussionsupporting
confidence: 54%
“…FPten flox/flox (n = 35) and FPten flox/+ (n = 31) mice (8-10 weeks) and their WT littermates (n = 40) were fed drinking water containing freshly prepared 0.025% (v/v) BBN (TCI America, Portland, OR) as described (28). To analyze the onset of urothelial tumors, randomly selected mice were sacrificed at week 8 ( , and 6 FPten flox/flox ) after BBN treatment and examined histologically.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Subsequently, it has taken its rightful place among the major signaling pathways controlling animal development, being found to regulate the morphogenesis of a variety of tissues and organs during the development of organisms ranging from Drosophila to human (McMahon et al 2003). In addition, the Hh pathway has been linked to multiple forms of human cancer, (Hahn et al 1996;Johnson et al 1996) Medulloblastoma (Goodrich et al 1997;Berman et al 2002) Rhabdomyosarcoma (Hahn et al 1996;Kappler et al 2004) Glioma (Kinzler et al 1987) Breast cancer (Kubo et al 2004) Esophageal cancer Watkins and Peacock 2004) Gastric cancer ) Pancreatic cancer (Thayer et al 2003) Prostate cancer Sanchez et al 2004) Small-cell lung cancer ) Biliary tract cancer ) Bladder cancer (Hamed et al 2004) Oral cancer (Nishimaki et al 2004) Mutations in Hh pathway components have been identified in BCC, medulloblastoma, rhabdomyosarcoma, and glioma (top).…”
Section: Perspectivementioning
confidence: 99%
“…13 In a mouse Table 2) model, it has been shown that Ptch −/− mice show increased susceptibility to carcinogen-induced bladder tumorigenesis, which provides additional support for a suppressor function in the bladder. 15 However, further studies are required to confi rm a role in human bladder cancer. Similarly, the DBC1 gene (9q33) has been implicated by mapping studies.…”
Section: Molecular Events In Specifi C Tumor Groupsmentioning
confidence: 99%